If we want to decrease disparities in getting care to patients with cancer, our largest opportunity is in prevention and early detection. Project ECHO makes this dream possible. It’s a highly effective, affordable and scalable platform.

Dr. Richard Wender
Chief Cancer Control Officer, American Cancer Society

Revolutionizing Cancer Care Delivery


Despite a dramatic increase in innovation, treatments and best practices to improve cancer care, cancer disparities are increasing. Over 90% of medical oncologists practice in urban areas, leaving rural communities without the capacity to screen, diagnose and treat patients with cancer, many of whom are diagnosed at later and less treatable stages.

Nowhere is this problem more evident than in rural America. For all five leading causes of death in the United States — heart disease, stroke, cancer, unintentional injury and chronic lower respiratory disease — rural areas have higher mortality rates than cities and suburbs. The mortality gap in cancer is especially stark — people in nonmetropolitan counties are more likely to die from cancer than their urban and suburban counterparts even though they have lower rates of diagnosis, the Centers for Disease Control and Prevention recently reported. And that gap is widening.

The ECHO model delivers specialty expertise to underserved areas. The platform uses case based learning to build local capacity, providing communities with the tools needed to deliver care comparable to that of academic specialists.

The ECHO model can amplify the work of your organization to share best practices and increase provider satisfaction, self-efficacy, and capacity to decrease cancer disparities globally.

Read Dr. Arora’s recent article: Quality medical care in rural communities is out of reach for millions
 
 

 
 

What are the Focal Areas for Developing Cancer Expertise?

Prevention

  • Cancer control planning
  • Community cancer intervention & prevention
  • Hepatitis B & C treatment
  • Hepatitis B vaccination
  • HPV vaccination
  • Smoking/tobacco cessation
  • Sun safety & skin cancer prevention
Screening

  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Dermatology
  • Oral & lung cancer
  • Pathology best practices
  • Training peer and community health advocates
Treatment

  • Cancer care navigation
  • Clinical trial enrollment
  • Clinical Trials
  • Palliative Care
  • Pain & toxicity management
  • Precision medicine & genomics
  • Survivorship
  • Tumor Boards

 
 

MetaECHO Conferences

  • SAVE THE DATE for the next MetaECHO, March 13-26, 2019
  • 2014 MetaECHO: Project ECHO: Cervical Cancer Prevention – Sound Waves from the Field

  • Ernest Hawk, MD, MPH, Vice President of Cancer Prevention & Population Sciences
    MD Anderson Cancer Center Project ECHO Superhub

  • 2017 MetaECHO: Project ECHO: Mobilizing the ECHO Model in Cancer

    Moderator: Patti Doykos, PhD, Director, Bristol-Myers Squibb Foundation
    Panelists: Roopa Hariprasad, MD, Scientist-D, Division of Clinical Oncology, National Institute of Cancer Prevention and Research (NICPR)
    Brenda Kostelecky, PhD, Lead for Cancer Control Planning and Policy at the National Cancer Institute Center for Global Health
    Kathleen Schmeler, MD, Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine, Director of the colposcopy clinics at MD Anderson Cancer Center and LBJ Hospital
    Richard Wender, MD, Chief Cancer Control Officer, American Cancer Society

 
 

Cancer ECHO Partners

New Launches!

Read More About the Effectiveness of ECHO for Cancer

Learn More About Project ECHO

  • Attend Introduction: Join us for a 90 minute ECHO Introduction videoconference to learn more about the ECHO model (held monthly).
  • Become an ECHO Partner: Learn how to Start an ECHO and attend ECHO Immersion (a free, three day on-site training at the ECHO Institute in Albuquerque, New Mexico, U.S.A.)

 
Contact us at cancerECHO@salud.unm.edu to explore opportunities for collaboration with our Cancer ECHO team. Learn more about our partnership with the Bristol-Myers Squibb Foundation and their support of this initiative.